Works matching AU Papaioannou, M.


Results: 27
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY.

    Published in:
    HemaSphere, 2022, v. 6, p. 20, doi. 10.1097/01.HS9.0000829636.39178.19
    By:
    • Terpos, E;
    • Ntanasis‐Stathopoulos, I;
    • Kastritis, E;
    • Hatjiharissi, E;
    • Katodritou, E;
    • Eleutherakis‐Papaiakovou, E;
    • Verrou, E;
    • Gavriatopoulou, M;
    • Leonidakis, A;
    • Delimpasi, S;
    • Malandrakis, P;
    • Kyrtsonis, M‐C;
    • Papaioannou, M;
    • Symeonidis, A;
    • Dimopoulos, MA
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology.

    Published in:
    Annals of Hematology, 2006, v. 85, n. 4, p. 250, doi. 10.1007/s00277-005-0066-0
    By:
    • Matsouka, P.;
    • Pagoni, M.;
    • Zikos, P.;
    • Giannakoulas, N.;
    • Apostolidis, I.;
    • Asprogeraka, T.;
    • Arvanitopoulou, E.;
    • Spanoudakis, E.;
    • Kotsianidis, I.;
    • Tsatalas, K.;
    • Papaioannou, M.;
    • Marinakis, T.;
    • Skandali, A.;
    • Viniou, N.;
    • Yataganas, X.;
    • Bakiri, M.
    Publication type:
    Article